- Home
- VITL vs BME Comparison
VITL vs BME Comparison
Compare VITL & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VITL | BME |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Staples | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 588.6M | 547.5M |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | VITL | BME |
|---|---|---|
| Price | $12.66 | $38.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $37.90 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 45.6K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.03 | N/A |
| EPS | ★ 1.44 | N/A |
| Revenue | ★ $759,444,000.00 | N/A |
| Revenue This Year | $21.13 | N/A |
| Revenue Next Year | $18.17 | N/A |
| P/E Ratio | $8.74 | ★ N/A |
| Revenue Growth | ★ 25.26 | N/A |
| 52 Week Low | $12.35 | $34.18 |
| 52 Week High | $53.13 | $42.74 |
Technical Indicators
Market Signals| Indicator | VITL | BME |
|---|---|---|
| Relative Strength Index (RSI) | 20.37 | 39.68 |
| Support Level | N/A | $35.48 |
| Resistance Level | $33.73 | $42.34 |
| Average True Range (ATR) | 0.90 | 0.72 |
| MACD | 0.19 | -0.02 |
| Stochastic Oscillator | 4.76 | 46.66 |
Price Performance
Historical ComparisonAbout VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.